0001362118-21-000051.txt : 20211207
0001362118-21-000051.hdr.sgml : 20211207
20211207155226
ACCESSION NUMBER: 0001362118-21-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190930
FILED AS OF DATE: 20211207
DATE AS OF CHANGE: 20211207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Velge Bertrand
CENTRAL INDEX KEY: 0001758339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 211475925
MAIL ADDRESS:
STREET 1: BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND
STREET 2: ROMNEY MARSH
CITY: KENT
STATE: X0
ZIP: TN299TR
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-09-30
0
0000948320
LifeMD, Inc.
LFMD
0001758339
Velge Bertrand
C/O LIFEMD, INC.
800 THIRD AVE STE 2800
NEW YORK
NY
10022
1
0
0
0
Common Stock
217391
D
Common Stock
2020-04-15
4
P
0
294118
0.17
A
511509
D
Common Stock
2020-08-05
4
A
0
173234
0
A
684743
D
Common Stock
2020-09-22
4
P
0
96923
0.65
A
781666
D
Common Stock
2021-12-03
4
P
0
110000
3.91
A
891666
I
By Aliunde LLC
Warrants to Purchase Common Stock
0.28
2019-05-15
2023-05-15
Common Stock
217391
217391
D
Stock Option (Right to Buy)
1.15
2019-09-30
4
A
0
2500
0
A
2019-09-30
2024-09-30
Common Stock
2500
2500
D
Stock Option (Right to Buy)
1.15
2019-12-31
4
A
0
2500
0
A
2019-12-31
2024-12-31
Common Stock
2500
2500
D
Stock Option (Right to Buy)
1.2
2020-03-31
4
A
0
2500
0
A
2021-03-31
2025-03-31
Common Stock
2500
2500
D
Stock Option (Right to Buy)
1.5
2020-06-30
4
A
0
2500
0
A
2020-06-30
2025-06-30
Common Stock
2500
2500
D
Warrants to Purchase Common Stock
4.65
2020-09-22
4
A
0
100000
0
A
2020-09-22
2024-09-22
Common Stock
100000
100000
D
Stock Option (Right to Buy)
7.95
2020-09-30
4
A
0
2500
0
A
2020-09-30
2025-09-30
Common Stock
2500
2500
D
Stock Option (Right to Buy)
7
2020-12-31
4
A
0
2500
0
A
2020-12-31
2025-12-31
Common Stock
2500
2500
D
Stock Option (Right to Buy)
11.98
2021-03-31
4
A
0
2500
0
A
2021-03-31
2026-03-31
Common Stock
2500
2500
D
Stock Option (Right to Buy)
11.56
2020-06-30
4
A
0
2500
0
A
2021-06-30
2026-06-30
Common Stock
2500
2500
D
On October 14, 2020, the common stock of LFMD, Inc. had a reverse stock split 1-for-5, resulting in a decrease of the reporting person's ownership of 869,566 shares of common stock.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt.
Issued as director's compensation.
Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019.
/s/ Bertrand Velge
2021-12-07